 <h1>Carteolol Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li>Breastfeeding</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to carteolol: oral tablet</i></p><h3>General</h3><p>Carteolol is generally well-tolerated.  Side effects are usually mild and transient.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects include headache in up to 1% to 17%, asthenia in 8%, insomnia in 5%, dizziness in 8%, paresthesias in 2%, and vertigo, nervousness, headache or fatigue in 1% of patients.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular problems include chest pain in 2% and edema in 1% of patients.  Carteolol may cause or worsen AV heart block.  In the rare cases of new or worsened congestive heart failure that are associated with carteolol, a cause-and-effect relationship is not established.<sup>[Ref]</sup></p><p>The etiology of "chest pain" was not described in studies and reviews from the medical literature.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal complaints of abdominal or epigastric pain in 1% to 7% and diarrhea or nausea in 2% of patients is reported.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects are rare.  Cough, pharyngitis, or sinusitis are reported in 1% to 5% of patients.  Dyspnea is reported rarely.  Patients with a history of reactive airways disease may be more likely to become short of breath while taking carteolol, as during therapy with any beta-blocker.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Carteolol and pindolol, beta-adrenergic receptor antagonists with intrinsic sympathomimetic activity (ISA), have more commonly been associated with muscle cramps and elevated serum creatine phosphokinase (CK) levels than beta-blockers without ISA.<sup>[Ref]</sup></p><p>Musculoskeletal pain is reported in approximately 3% to 13% of patients.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary complaints of impotence are reported in less than 1% of male patients.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Psychiatric side effects including reports of depression have been associated with carteolol.<sup>[Ref]</sup></p><p id="ref_1">1. "Multum Information Services, Inc. Expert Review Panel"  </p><p id="ref_2">2. Luther RR, Glassman HN, Jordan DC "A comparison of carteolol and nadolol in the treatment of stable angina pectoris." J Clin Pharmacol 28 (1988): 634-9</p><p id="ref_3">3. Simon H, Schuppan U "The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol." Arzneimittelforschung 33 (1983): 318-21</p><p id="ref_4">4. Luther RR, Maurath CJ, Klepper MJ, Peckinpaugh RO, Ringham GL "Carteolol treatment of essential hypertension: a long-term study of safety and efficacy." J Int Med Res 14 (1986): 175-84</p><p id="ref_5">5. Tarkiainen A, Saraste K, Seppala T, Gordin A, Auvinen J "A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride." Eur J Clin Pharmacol 19 (1981): 239-44</p><p id="ref_6">6. Luther RR, Glassman HN, Jordan DC, Klepper MJ "Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent." J Int Med Res 14 (1986): 167-74</p><p id="ref_7">7. Velasquez MT, Byrne D, Hoffmann RG "Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects." J Clin Pharmacol 25 (1985): 601-6</p><p id="ref_8">8. Frishman WH, Covey S "Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism." J Clin Pharmacol 30 (1990): 412-21</p><p id="ref_9">9. "Carteolol and penbutolol for hypertension." Med Lett Drugs Ther 31 (1989): 70-1</p><p id="ref_10">10. Imai Y, Watanabe N, Hashimoto J, Nishiyama A, Sakuma H, Sekino H, Omata K, Abe K "Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers." Eur J Clin Pharmacol 48 (1995): 29-34</p><h2>More about carteolol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: non-cardioselective beta blockers</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>